LONGUEUIL, QC, Aug. 8, 2023 /CNW/ - Héroux-Devtek Inc. (TSX: HRX) ("Héroux-Devtek" or the "Corporation"), a leading international manufacturer of aerospace products and the world's third-largest landing gear manufacturer, today announced that the Toronto Stock Exchange ("TSX") has approved Héroux‑Devtek's normal course issuer bid ("NCIB"). Under the NCIB, Héroux-Devtek has the right to purchase for cancellation, from August 10, 2023 to August 9, 2024, a maximum of 1,791,984 common shares, representing, as of August 2, 2023, 10% of the public float of 17,919,842 common shares. The Corporation had 34,005,873 common shares issued and outstanding as of August 2, 2023.
Read more at newswire.caHÉROUX-DEVTEK ANNOUNCES NORMAL COURSE ISSUER BID
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
